Table 1. Compounds and example prescription opioid medication products tracked by ASI-MV and included in analysis.
| Compound | Example product: brand name or generic and manufacturer |
| Oxycodone extended release | OxyContin (before reformulation), oxycodone ER-Endo Pharmaceuticals |
| Oxycodone combination immediate release | Percocet, Tylox |
| Hydrocodone | Vicodin, Lortab |
| Meperidine | Demerol |
| Propoxyphene | Darvocet, Darvon |
| Fentanyl | Duragesic, Fentora |
| Oxymorphone | Opana ER, Opana IR |
| Hydromorphone | Dilaudid, Palladone |
| Codeine | Tylenol with codeine |
| Morphine | MS Contin, KADIAN |
| Tramadol | Utram, Ultracet |
| Methadone* | methadone—Covidien Pharmaceuticals, methadone—Roxane Laboratories |
| Buprenorphine | Subutex, Suboxone |
| Pentazocine | Talwin |
| Butorphanol | Stadol |
*Includes methadone products used in the treatment of chronic pain only.
ER = extended release, IR = immediate release.
Note: This is a partial listing of the brand name and generic opioid analgesics tracked by ASI-MV and used in this analysis. Please contact Inflexxion, Inc. for the full list of products included in this analysis or for information on all Schedule II and III medications tracked by the ASI-MV.